Felipe Vilardell Villellas

Samain, R; Maiques, O; Monger, J; Lam, H; Candido, J; George, S; Ferrari, N; Kohihammer, L; Lunetto, S; Varela, A; Orgaz, JL; VILARDELL, F; Olsina, JJ; Matias-Guiu, X; Sarker, D; Biddle, A; Balkwill, FR; Eyles, J; Wilkinson, RW; Kocher, HM; Calvo, F; Wells, CM; Sanz-Moreno, V

CD73 controls Myosin II-driven invasion, metastasis, and immunosuppression in amoeboid pancreatic cancer cells

Science Advances 9 -. 20/10/2023.

[doi:10.1126/sciadv.adi0244]

Huerva V; Vilardell F; Cid-Bertomeu P

Cryotherapy after Topical Interferon Alpha 2b to Treat Conjunctival Primary Acquired Melanosis.

Case Reports In Ophthalmology 14 111-114. 22/03/2023.

[doi:10.1159/000529667]

Canal-Garcia E; Soria X; Vilardell F; Marti RM

Acral reed nevus with parallel ridge pattern: an exception to the rule of malignancy.

ANAIS BRASILEIROS DE DERMATOLOGIA 98 246-248. 01/03/2023.

[doi:10.1016/j.abd.2021.05.022]

Alturo-Pons A; Alamon-Reig F; Sanmartin Novell V; Vilardell F; Martí RM

[[Translated article]]Congenital and Acquired Epidermodysplasia Verruciformis: A Series of 7 Cases.

ACTAS DERMO-SIFILIOGRAFICAS 114 179-182. 01/12/2022.

[doi:10.1016/j.ad.2022.01.055]

Matas-Nadal C; Soria X; Gonzalez-Farré M; Baradad M; Tuset N; Rius Riu F; González M; Gatius S; Vilardell F; López-Ortega R; María Martí R

Abdominal tumors in patients with neurofibromatosis type I: Genotype-phenotype relationships.

European Journal of Medical Genetics 65 104609-104609. 01/11/2022.

[doi:10.1016/j.ejmg.2022.104609]

Alturo-Pons A; Alamon-Reig F; Sanmartin Novell V; Vilardell F; Martí RM

Congenital and Acquired Epidermodysplasia Verruciformis: A Series of 7 Cases.

ACTAS DERMO-SIFILIOGRAFICAS 114 179-182. 30/08/2022.

[doi:10.1016/j.ad.2022.01.048]

Vilaltella, M; Vilardell, F; Cid-Bertomeu, P; Huerva, V

IgG(4)-related orbital disease

CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE 57 78-79. 01/06/2022.

Belokopytova-Chakh, A; Ruiz-Gonzalez, A; Vilardell-Vilellas, F; Porcel, JM

Cardiac tamponade as the initial presentation of a T-cell lymphoblastic lymphoma

Galicia Clinica 83 42-44. 01/04/2022.

[doi:10.22546/65/2775]

Soria X; Vilardell F; Maiques Ó; Barceló C; Sisó P; de la Rosa I; Velasco A; Cuevas D; Santacana M; Gatius S; Matías-Guiu X; Rodrigo A; Macià A; Martí RM

BRAF(V600E)

Mutant Allele Frequency (MAF) Influences Melanoma Clinicopathologic Characteristics

Cancers 13 -. 11/10/2021.

[doi:10.3390/cancers13205073]

Vieites, B; Lopez-Garcia, MA; Martin-Salvago, MD; Ramirez-Tortosa, CL; Rezola, R; de Salas, MS; Vilaro, LL; Villellas, FV; Burgues, O; Fernandez-Rodriguez, B; Galan, LA; Peg, V

Patient follow-up of NEOVATTL study

ANNALS OF ONCOLOGY 32 49-49. 01/05/2021.

[doi:10.1016/j.annonc.2021.03.079]

Cudos, AG; Murillo, SM; Subirats, OP; Galindo, AR; Rodriguez, JV; Guzman, DRS; Villellas, FV; Morales, CC; Olive, JM; Martinez, EI

Assesment of endocrine sensitivity in primary breast cancer through RS Score and changes in the proliferation index KI67

BREAST 56 52-53. 01/04/2021.

Morales Murillo, Serafin; Gasol Cudos, Ariadna; Veas Rodriguez, Joel; Canosa Morales, Carles; Melé Olivé, Jordi; Vilardell Villellas, Felip; Sanchez Guzman, Douglas Rene; Iglesias Martínez, Edelmiro; Salud Salvia, Antonieta

Selection of neoadjuvant treatment based on the 21-GENE test results in luminal breast cancer

BREAST 56 35-41. 01/03/2021.

[doi:10.1016/j.breast.2021.01.001]